FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Donna Hollis

Research Profile

Procedures

Concepts & Ideas

Chemicals & Drugs

Disorders

Co-author Network

Publications

TOP 3
Shuji Ogino; Leonard B Saltz; Paul Schaefer; Kaori Shima; Donna Spiegelman; Renaud Whittom; Richard M Goldberg; Alexander Hantel; Donna Hollis; Robert J Mayer; Nadine J McCleary; Jeffrey A Meyerhardt; Kimmie Ng; Al B Benson; Monica M Bertagnolli; Charles S Fuchs
Predictive and prognostic roles of BRAF mutation in stage III colon cancer: results from intergroup trial CALGB 89803.
Federico Innocenti; Chen Jiang; Hedy L Kindler; Michiaki Kubo; Liang Li; Howard L McLeod; Taisei Mushiroda; Yusuke Nakamura; Kouros Owzar; Nancy L Cox; Patrick Evans; Paula Friedman; Kathleen M Giacomini; Dylan Glubb; Richard M Goldberg; Donna Hollis; Herbert Hurwitz; Richard L Schilsky; Liewei Wang; Hitoshi Zembutsu; Mark J Ratain
A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303.
Kimmie Ng; Donna Niedzwiecki; Shuji Ogino; Leonard B Saltz; Paul L Schaefer; Alan P Venook; Renaud Whittom; Al B Benson; Monica M Bertagnolli; Andrew T Chan; Jennifer A Chan; Richard M Goldberg; Alexander Hantel; Donna Hollis; Robert J Mayer; Jeffrey A Meyerhardt; Charles S Fuchs
Relationship between statin use and colon cancer recurrence and survival: results from CALGB 89803.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Donna Hollis (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Shuji Ogino; Leonard B Saltz; Paul Schaefer; Kaori Shima; Donna Spiegelman; Renaud Whittom; Richard M Goldberg; Alexander Hantel; Donna Hollis; Robert J Mayer; Nadine J McCleary; Jeffrey A Meyerhardt; Kimmie Ng; Al B Benson; Monica M Bertagnolli; Charles S Fuchs
Predictive and prognostic roles of BRAF mutation in stage III colon cancer: results from intergroup trial CALGB 89803.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(3):890-900.
2012: Federico Innocenti; Chen Jiang; Hedy L Kindler; Michiaki Kubo; Liang Li; Howard L McLeod; Taisei Mushiroda; Yusuke Nakamura; Kouros Owzar; Nancy L Cox; Patrick Evans; Paula Friedman; Kathleen M Giacomini; Dylan Glubb; Richard M Goldberg; Donna Hollis; Herbert Hurwitz; Richard L Schilsky; Liewei Wang; Hitoshi Zembutsu; Mark J Ratain
A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(2):577-84.
2011: Kimmie Ng; Donna Niedzwiecki; Shuji Ogino; Leonard B Saltz; Paul L Schaefer; Alan P Venook; Renaud Whittom; Al B Benson; Monica M Bertagnolli; Andrew T Chan; Jennifer A Chan; Richard M Goldberg; Alexander Hantel; Donna Hollis; Robert J Mayer; Jeffrey A Meyerhardt; Charles S Fuchs
Relationship between statin use and colon cancer recurrence and survival: results from CALGB 89803.
Journal of the National Cancer Institute 2011;103(20):1540-51.
2010: Jessica L Hubbs; Jessamy A Boyd; Donna Hollis; Junzo P Chino; Mert Saynak; Chris R Kelsey
Factors associated with the development of brain metastases: analysis of 975 patients with early stage nonsmall cell lung cancer.
Cancer 2010;116(21):5038-46.
2010: Kimmie Ng; Jeffrey A Meyerhardt; Jennifer A Chan; Donna Niedzwiecki; Donna Hollis; Leonard B Saltz; Robert J Mayer; Al B Benson; Paul L Schaefer; Renaud Whittom; Alexander Hantel; Richard M Goldberg; Charlie S Fuchs
Multivitamin use is not associated with cancer recurrence or survival in patients with stage III colon cancer: findings from CALGB 89803.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(28):4354-63.
2010: Hedy L Kindler; Donna Niedzwiecki; Donna Hollis; Susan Sutherland; Deborah Schrag; Herbert Hurwitz; Federico Innocenti; Mary Frances Mulcahy; Eileen O'Reilly; Timothy F Wozniak; Joel Picus; Pankaj Bhargava; Robert J Mayer; Richard L Schilsky; Richard M Goldberg
Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the Cancer and Leukemia Group B (CALGB 80303).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(22):3617-22.
2010: Nadine Jackson McCleary; Donna Niedzwiecki; Donna Hollis; Leonard B Saltz; Paul Schaefer; Renaud Whittom; Alexander Hantel; Al Benson; Richard M Goldberg; Jeffrey A Meyerhardt
Impact of smoking on patients with stage III colon cancer: results from Cancer and Leukemia Group B 89803.
Cancer 2010;116(4):957-66.
2010: Eileen M O'Reilly; Donna Niedzwiecki; Margaret Hall; Donna Hollis; Tanios Bekaii-Saab; Timothy Pluard; Kathe Douglas; Ghassan K Abou-Alfa; Hedy L Kindler; Richard L Schilsky; Richard M Goldberg
A Cancer and Leukemia Group B phase II study of sunitinib malate in patients with previously treated metastatic pancreatic adenocarcinoma (CALGB 80603).
The oncologist 2010;15(12):1310-9.
2009: Shuji Ogino; Jeffrey A Meyerhardt; Natsumi Irahara; Donna Niedzwiecki; Donna Hollis; Leonard B Saltz; Robert J Mayer; Paul Schaefer; Renaud Whittom; Alexander Hantel; Al B Benson; Richard M Goldberg; Monica M Bertagnolli; Charlie S Fuchs
KRAS mutation in stage III colon cancer and clinical outcome following intergroup trial CALGB 89803.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(23):7322-9.
2009: Antonius A Miller; Daryl J Murry; Kouros Owzar; Donna Hollis; Erin B Kennedy; Ghassan K Abou-Alfa; Apurva Desai; Jimmy Hwang; Miguel A Villalona-Calero; Elizabeth Dees; Lionel D Lewis; Marwan G Fakih; Martin J Edelman; Fred Millard; Richard C Frank; Raymond J Hohl; Mark J Ratain
Phase I and pharmacokinetic study of sorafenib in patients with hepatic or renal dysfunction: CALGB 60301.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(11):1800-5.
2008: Michael C Heinrich; Kouros Owzar; Christopher L Corless; Donna Hollis; Ernest C Borden; Christopher D M Fletcher; Christopher W Ryan; Margaret von Mehren; Charles D Blanke; Cathryn Rankin; Robert S Benjamin; Vivien H C Bramwell; George D Demetri; Monica M Bertagnolli; Jonathan A Fletcher
Correlation of kinase genotype and clinical outcome in the North American Intergroup Phase III Trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(33):5360-7.
2008: Jeffrey A Meyerhardt; Donna Niedzwiecki; Donna Hollis; Leonard B Saltz; Robert J Mayer; Heidi Nelson; Renaud Whittom; Alexander Hantel; James P Thomas; Charlie S Fuchs
Impact of body mass index and weight change after treatment on cancer recurrence and survival in patients with stage III colon cancer: findings from Cancer and Leukemia Group B 89803.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(25):4109-15.
2008: Jennifer A Chan; Jeffrey A Meyerhardt; Donna Niedzwiecki; Donna Hollis; Leonard B Saltz; Robert J Mayer; James P Thomas; Paul Schaefer; Renaud Whittom; Alexander Hantel; Richard M Goldberg; Robert S Warren; Monica Bertagnolli; Charlie S Fuchs
Association of family history with cancer recurrence and survival among patients with stage III colon cancer.
JAMA : the journal of the American Medical Association 2008;299(21):2515-23.
2008: Joel E Tepper; Mark J Krasna; Donna Niedzwiecki; Donna Hollis; Carolyn E Reed; Richard M Goldberg; Krystyna Kiel; Christopher G Willett; David Sugarbaker; Robert Mayer
Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(7):1086-92.
2007: Jeffrey A Meyerhardt; Donna Niedzwiecki; Donna Hollis; Leonard B Saltz; Frank B Hu; Robert J Mayer; Heidi Nelson; Renaud Whittom; Alexander Hantel; James P Thomas; Charlie S Fuchs
Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer.
JAMA : the journal of the American Medical Association 2007;298(7):754-64.
2007: Leonard B Saltz; Donna Niedzwiecki; Donna Hollis; Richard M Goldberg; Alexander Hantel; James P Thomas; Anthony L A Fields; Robert J Mayer
Irinotecan fluorouracil plus leucovorin is not superior to fluorouracil plus leucovorin alone as adjuvant treatment for stage III colon cancer: results of CALGB 89803.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(23):3456-61.
2007: Antonius A Miller; Daryl J Murry; Kouros Owzar; Donna Hollis; Lionel D Lewis; Hedy L Kindler; John L Marshall; Miguel A Villalona-Calero; Martin J Edelman; Raymond J Hohl; Stuart M Lichtman; Mark J Ratain
Phase I and pharmacokinetic study of erlotinib for solid tumors in patients with hepatic or renal dysfunction: CALGB 60101.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(21):3055-60.
2007: Lionel D Lewis; Antonius A Miller; Gary Rosner; Jonathan E Dowell; Manuel Valdivieso; Mary Relling; Merrill J Egorin; Robert R Bies; Donna Hollis; Ellis G Levine; Gregory A Otterson; Frederick Millard; Mark J Ratain
A comparison of the pharmacokinetics and pharmacodynamics of docetaxel between African-American and Caucasian cancer patients: CALGB 9871.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(11):3302-11.
2006: Jeffrey A Meyerhardt; Denise Heseltine; Donna Niedzwiecki; Donna Hollis; Leonard B Saltz; Robert J Mayer; James P Thomas; Heidi Nelson; Renaud Whittom; Alexander Hantel; Richard L Schilsky; Charlie S Fuchs
Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(22):3535-41.
2006: David P Ryan; Donna Niedzwiecki; Donna Hollis; Brent E Mediema; Scott Wadler; Joel E Tepper; Richard M Goldberg; Robert J Mayer
Phase I/II study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: Cancer and Leukemia Group B 89901.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(16):2557-62.
2006: Stuart M Lichtman; Donna Hollis; Antonius A Miller; Gary Rosner; Chris A Rhoades; Eric P Lester; Frederick Millard; John Byrd; Stephen A Cullinan; D Marc Rosen; Robert A Parise; Mark J Ratain; Merrill J Egorin
Prospective evaluation of the relationship of patient age and paclitaxel clinical pharmacology: Cancer and Leukemia Group B (CALGB 9762).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(12):1846-51.
2006: Nancy Kemeny; Donna Niedzwiecki; Donna Hollis; Heinz-Josef Lenz; Robert S Warren; Michelle J Naughton; Jane C Weeks; Elin R Sigurdson; James E Herndon; Chunfeng Zhang; Robert J Mayer
Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(9):1395-403.
2006: Cheri E Klein; Helen Kastrissios; Antonius A Miller; Donna Hollis; Daohai Yu; Gary Rosner; David L Grinblatt; Richard A Larson; Mark J Ratain
Pharmacokinetics, pharmacodynamics and adherence to oral topotecan in myelodysplastic syndromes: a Cancer and Leukemia Group B study.
Cancer chemotherapy and pharmacology 2006;57(2):199-206.
2005: Walter M Stadler; Gary Rosner; Eric Small; Donna Hollis; Brian I Rini; S Donald Zaentz; John Mahoney; Mark J Ratain
Successful implementation of the randomized discontinuation trial design: an application to the study of the putative antiangiogenic agent carboxyaminoimidazole in renal cell carcinoma--CALGB 69901.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(16):3726-32.
2004: Antonius A Miller; Gary Rosner; Merrill J Egorin; Donna Hollis; Stuart M Lichtman; Mark J Ratain
Prospective evaluation of body surface area as a determinant of paclitaxel pharmacokinetics and pharmacodynamics in women with solid tumors: Cancer and Leukemia Group B Study 9763.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(24):8325-31.
2004: Jeffrey A Meyerhardt; Joel E Tepper; Donna Niedzwiecki; Donna Hollis; A David McCollum; Denise Brady; Michael J O'Connell; Robert J Mayer; Bernard Cummings; Christopher Willett; John S Macdonald; Al B Benson; Charlie S Fuchs
Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from Intergroup Trial 0114.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(4):648-57.
2004: Jeffrey A Meyerhardt; Joel E Tepper; Donna Niedzwiecki; Donna Hollis; Deborah Schrag; John Z Ayanian; Michael J O'Connell; Jane C Weeks; Robert J Mayer; Christopher G Willett; John S Macdonald; Al B Benson; Charlie S Fuchs
Impact of hospital procedure volume on surgical operation and long-term outcomes in high-risk curatively resected rectal cancer: findings from the Intergroup 0114 Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(1):166-74.
2003: Joel E Tepper; M O'Connell; Donna Hollis; Donna Niedzwiecki; E Cooke; Robert J Mayer
Analysis of surgical salvage after failure of primary therapy in rectal cancer: results from Intergroup Study 0114.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(19):3623-8.
2003: Wallace Akerley; James E Herndon; Merrill J Egorin; Alan P Lyss; Hedy L Kindler; Dianne M Savarese; Carol A Sherman; D Marc Rosen; Donna Hollis; Mark J Ratain; Mark R Green
Weekly, high-dose paclitaxel in advanced lung carcinoma: a phase II study with pharmacokinetics by the Cancer and Leukemia Group B.
Cancer 2003;97(10):2480-6.
2003: A. William Blackstock; Joel E Tepper; Donna Niedwiecki; Donna Hollis; Robert J Mayer; Margaret A Tempero
Cancer and leukemia group B (CALGB) 89805: phase II chemoradiation trial using gemcitabine in patients with locoregional adenocarcinoma of the pancreas.
International journal of gastrointestinal cancer 2003;34(2-3):107-16.
2002: Gini F Fleming; Neal J Meropol; Gary Rosner; Donna Hollis; William E Carson; Michael Caligiuri; Joanne Mortimer; Katherine Tkaczuk; Robin Parihar; Richard L Schilsky; Mark J Ratain
A phase I trial of escalating doses of trastuzumab combined with daily subcutaneous interleukin 2: report of cancer and leukemia group B 9661.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(12):3718-27.
2002: Joel E Tepper; M O'Connell; Donna Niedzwiecki; Donna Hollis; Al B Benson; Bernard Cummings; Leonard L Gunderson; John S Macdonald; James A Martenson; Robert J Mayer
Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control--final report of intergroup 0114.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(7):1744-50.
2001: Joel E Tepper; Michael J O'Connell; Donna Niedzwiecki; Donna Hollis; Carolyn Corlies Compton; Al B Benson; Bernard Cummings; Leonard L Gunderson; John S Macdonald; Robert J Mayer
Impact of number of nodes retrieved on outcome in patients with rectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(1):157-63.
2000: Alan P Venook; Merrill J Egorin; Gary Rosner; Donna Hollis; Sridhar Mani; M Hawkins; John Byrd; R Hohl; D Budman; N J Meropol; Mark J Ratain
Phase I and pharmacokinetic trial of gemcitabine in patients with hepatic or renal dysfunction: Cancer and Leukemia Group B 9565.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(14):2780-7.
1998: Rogerio Lilenbaum; Antonius A Miller; G Batist; Stephen A Bernard; Donna Hollis; Gary Rosner; Merrill J Egorin; Richard L Schilsky; M J Ratain
Phase I and pharmacologic study of continuous infusion topotecan in combination with cisplatin in patients with advanced cancer: a Cancer and LeukemiaGroup B study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(10):3302-9.
1997: Antonius A Miller; Gary Rosner; M J Ratain; Donna Hollis; M R Green; Richard L Schilsky
Pharmacology of 21-day oral etoposide given in combination with i.v. cisplatin in patients with extensive-stage small cell lung cancer: a cancer and leukemia group B study (CALGB 9062).
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(5):719-25.
1997: Joel E Tepper; Michael J O'Connell; G R Petroni; Donna Hollis; E Cooke; Al B Benson; Bernard Cummings; Leonard L Gunderson; John S Macdonald; James A Martenson
Adjuvant postoperative fluorouracil-modulated chemotherapy combined with pelvic radiation therapy for rectal cancer: initial results of intergroup 0114.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(5):2030-9.
1996: Gary Rosner; J B Hargis; Donna Hollis; D R Budman; R B Weiss; I C Henderson; Richard L Schilsky
Relationship between toxicity and obesity in women receiving adjuvant chemotherapy for breast cancer: results from cancer and leukemia group B study 8541.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(11):3000-8.
1995: R C Lilenbaum; M J Ratain; Antonius A Miller; J B Hargis; Donna Hollis; Gary Rosner; S M O'Brien; L Brewster; M R Green; Richard L Schilsky
Phase I study of paclitaxel and topotecan in patients with advanced tumors: a cancer and leukemia group B study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(9):2230-7.
1995: Antonius A Miller; J E Herndon; Donna Hollis; J Ellerton; A Langleben; F Richards; M R Green
Schedule dependency of 21-day oral versus 3-day intravenous etoposide in combination with intravenous cisplatin in extensive-stage small-cell lung cancer: a randomized phase III study of the Cancer and Leukemia Group B.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(8):1871-9.